Myriad Genetics Inc (MYGN)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -127,300 -116,000 -155,200 -234,600 -263,300 -274,400 -248,200 -146,200 -112,000 -77,300 -17,600 -8,200 -27,200 -63,800 -103,600 -154,300 -230,000 -194,100 -199,500 -148,300
Total assets US$ in thousands 1,027,600 1,081,300 1,085,100 1,110,500 1,146,500 1,149,100 1,187,200 1,169,300 1,198,700 1,212,000 1,210,200 1,255,400 1,320,700 1,335,900 1,360,300 1,336,900 1,418,800 1,444,500 1,404,600 1,446,700
ROA -12.39% -10.73% -14.30% -21.13% -22.97% -23.88% -20.91% -12.50% -9.34% -6.38% -1.45% -0.65% -2.06% -4.78% -7.62% -11.54% -16.21% -13.44% -14.20% -10.25%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-127,300K ÷ $1,027,600K
= -12.39%

Myriad Genetics Inc's return on assets (ROA) has shown a declining trend over the data periods provided. The ROA ranged from -10.25% to -23.88% during the analyzed period. This indicates that the company's ability to generate profits from its assets has deteriorated over time. A negative ROA signifies that the company is not effectively utilizing its assets to generate income. Myriad Genetics Inc may need to evaluate its asset management strategies and implement measures to improve the efficiency of its asset utilization in order to enhance its overall financial performance.